CARTER, Ronald F. Do you believe that N-of-1 trials (a clinical trial in which a single patient is the entire trial), are appropriate to evaluate the effectiveness of genomic therapies for rare and/or common genetic disorders? Do gene-editing/targeting therapies have the potential to expedite the advancement of personalized medicine?. Health Science Inquiry, [S. l.], v. 8, n. 1, p. Page 60-Page 61, 2017. DOI: 10.29173/hsi223. Disponível em: https://healthscienceinquiry.com/index.php/hsi/article/view/223. Acesso em: 29 apr. 2025.